EDYNZI Trademark

Trademark Overview


On Monday, July 1, 2024, a trademark application was filed for EDYNZI with the United States Patent and Trademark Office. The USPTO has given the EDYNZI trademark a serial number of 98627133. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, October 21, 2024. This trademark is owned by N.V. ORGANON. The EDYNZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of bone diseases, metabolic diseases, cancer, and complications associated with the foregoing
edynzi

General Information


Serial Number98627133
Word MarkEDYNZI
Filing DateMonday, July 1, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of bone diseases, metabolic diseases, cancer, and complications associated with the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameN.V. ORGANON
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOSS 5349AB
NL

Trademark Events


Event DateEvent Description
Monday, July 1, 2024NEW APPLICATION ENTERED
Monday, July 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 21, 2024ASSIGNED TO EXAMINER